Table 2.
Descriptive statistics and internal consistency of key study variables at each assessment time point.
| Study Variable | T1 | T2 | T3 |
|---|---|---|---|
| Fatigue Interference | |||
| N | 226 † | 189 | 190 |
| M | 3.63 | 2.88 | 2.53 |
| SD | 1.97 | 1.77 | 1.63 |
| α | 0.9 | 0.9 | 0.9 |
| Pain Severity | |||
| N | 226 † | 189 | 190 |
| M | 2.28 | 1.90 | 1.81 |
| SD | 1.62 | 1.58 | 1.54 |
| α | 0.9 | 0.9 | 0.9 |
| Rejection Issues | |||
| N | 229 † | 184 | 184 |
| M | 3.70 | 3.46 | 3.40 |
| SD | 1.73 | 1.23 | 0.99 |
| α | 0.8 | 0.6 | 0.4 |
| Depressive Symptoms | |||
| N | 231 † | 195 | 180 |
| M | 7.52 | 6.03 | 5.96 |
| SD | 5.46 | 5.10 | 5.02 |
| α | 0.8 | 0.8 | 0.8 |
| Pain Medication | |||
| % (N) Yes | 25.0 (60) | 10.0 (24) | 10.0 (24) |
| % (N) No | 75.0 (180) | 70.4 (169) | 69.2 (166) |
| Anti-Depressants | |||
| % (N) Yes * | 10.8 (26) | 9.6 (23) | 12.1 (29) |
| % (N) No | 89.2 (214) | 70.8 (170) | 67.1 (161) |
| Sleep Medication | |||
| % (N) Yes | 17.9 (43) | 9.2 (22) | 11.7 (28) |
| % (N) No | 82.1 (197) | 70.8 (170) | 67.9 (163) |
| Anti-Anxiety Medication | |||
| % (N) Yes | 17.5 (42) | 12.1 (29) | 14.2 (34) |
| % (N) No | 82.5 (198) | 68.3 (164) | 65.0 (156) |
* unspecified as to whether participants were on anti-depressants for depression or to manage treatment side effects such as hot flashes; † Although N = 240 were enrolled and completed baseline assessments, smaller sample size for these measures at baseline are due to missing data on one or more study variables and listwise deletion. Note: Percentages that do not equal 100% are due to occasional missing data.